LLY vs META: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-01.
Eli Lilly and Company · Healthcare
$934.34
+17.6% upside to fair value
Grade B
High Quality
VS
Meta Platforms, Inc. · Communication Services
$671.34
+36.4% upside to fair value
Grade B
High Quality
QuantHub Verdict
META has more upside to fair value
(+36.4%).
META trades at a lower forward P/E
(28.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
META |
| Current Price |
$934.34 |
$671.34 |
| Fair Value Estimate |
$1,098.43 |
$916.00 |
| Upside to Fair Value |
+17.6%
|
+36.4%
|
| Market Cap |
$882.8B |
$1,698.2B |
| Forward P/E |
33.1x
|
28.0x
|
| EV / EBITDA |
27.9x
|
16.5x
|
| Price / Sales |
12.2x
|
8.4x
|
| Price / FCF |
65.0x
|
36.8x
|
| Revenue Growth YoY |
+55.5%
|
+23.8%
|
| Gross Margin |
82.7%
|
82.0%
|
| Operating Margin |
46.3%
|
41.4%
|
| Return on Equity |
101.3%
|
30.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.54%
|
2.72%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Eli Lilly and Company is a leading global pharmaceutical firm with a dominant position in the diabetes and obesity markets, driven by its blockbuster GLP-1 drugs Mounjaro and Zepbound which generated $36.5 billion in FY2025. The company reported $65.2 billion in total revenue for 2025, making it the top pharma by revenue globally. It exhibits high business quality with a durable competitive moat …
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Accumulation Zones
| Metric |
LLY |
META |
| Zone Low |
$823.82 |
$687.00 |
| Zone High |
$933.67 |
$778.60 |
| In Buy Zone? |
No
|
Yes
|